NCT04977024 2026-02-11SARS-CoV-2 Vaccine (GEO-CM04S1) Versus mRNA SARS-COV-2 Vaccine in Patients With Blood CancerGeoVax, Inc.Phase 2 Active not recruiting63 enrolled
NCT05119855 2026-02-05Safety and Immunogenicity of 9-valent Human Papillomavirus (9vHPV) Vaccine Coadministered With Messenger Ribonucleic Acid (mRNA)-1273 Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) (COVID-19) Vaccine (V503-076)Merck Sharp & Dohme LLCPhase 3 Completed165 enrolled 13 charts